tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Zydus Unveils World’s First Nivolumab Biosimilar in India to Broaden Cancer Care Access
Company AnnouncementsZydus Unveils World’s First Nivolumab Biosimilar in India to Broaden Cancer Care Access
2d ago
Zydus Lifesciences Opens Special Six-Month Window for Re-Lodgement of Physical Share Transfers
PremiumCompany Announcements
Zydus Lifesciences Opens Special Six-Month Window for Re-Lodgement of Physical Share Transfers
28d ago
Zydus Lifesciences Ties Up With Myriad Genetics to Bring Advanced Cancer-Risk Tests to India
PremiumCompany Announcements
Zydus Lifesciences Ties Up With Myriad Genetics to Bring Advanced Cancer-Risk Tests to India
1M ago
Zydus Lifesciences Secures Shareholder Approval for Fundraising Initiative
PremiumCompany Announcements
Zydus Lifesciences Secures Shareholder Approval for Fundraising Initiative
1M ago
Zydus Lifesciences Issues Notice on Lost Share Certificate
PremiumCompany Announcements
Zydus Lifesciences Issues Notice on Lost Share Certificate
2M ago
Zydus Lifesciences Releases Unaudited Financial Results for Q2 2025
PremiumCompany AnnouncementsZydus Lifesciences Releases Unaudited Financial Results for Q2 2025
3M ago
Zydus Lifesciences Completes Full Acquisition of Amplitude Surgical
Premium
Company Announcements
Zydus Lifesciences Completes Full Acquisition of Amplitude Surgical
3M ago
Zydus Lifesciences Gains Health Canada Approval for Mesalamine Suppositories
Premium
Company Announcements
Zydus Lifesciences Gains Health Canada Approval for Mesalamine Suppositories
3M ago
Zydus Lifesciences Issues Notice on Lost Share Certificate
PremiumCompany Announcements
Zydus Lifesciences Issues Notice on Lost Share Certificate
4M ago
Zydus Lifesciences Receives Upgraded USFDA Classification for Oncology Facility
PremiumCompany Announcements
Zydus Lifesciences Receives Upgraded USFDA Classification for Oncology Facility
4M ago
Zydus and Synthon Partner for U.S. Launch of Generic Ozanimod Capsules
PremiumCompany Announcements
Zydus and Synthon Partner for U.S. Launch of Generic Ozanimod Capsules
5M ago
Zydus Lifesciences Issues Notice on Lost Share Certificate
PremiumCompany Announcements
Zydus Lifesciences Issues Notice on Lost Share Certificate
7M ago
Zydus Lifesciences Addresses USFDA Inspection Observations at Gujarat Facility
PremiumCompany AnnouncementsZydus Lifesciences Addresses USFDA Inspection Observations at Gujarat Facility
9M ago
Zydus Lifesciences Announces Loss of Share Certificate
Premium
Company Announcements
Zydus Lifesciences Announces Loss of Share Certificate
10M ago
Zydus Lifesciences Gains USFDA Approval for Eluxadoline Tablets
Premium
Company Announcements
Zydus Lifesciences Gains USFDA Approval for Eluxadoline Tablets
10M ago
Zydus Lifesciences Achieves Successful USFDA Inspection at Ankleshwar Facility
PremiumCompany Announcements
Zydus Lifesciences Achieves Successful USFDA Inspection at Ankleshwar Facility
11M ago
Zydus Lifesciences Gains USFDA Approval for Methenamine Hippurate Tablets
PremiumCompany Announcements
Zydus Lifesciences Gains USFDA Approval for Methenamine Hippurate Tablets
11M ago
Zydus Lifesciences Unveils Financial Results for Q3 & 9M FY25
PremiumCompany Announcements
Zydus Lifesciences Unveils Financial Results for Q3 & 9M FY25
12M ago
Zydus Lifesciences Reports Strong Q3 Financial Growth
PremiumCompany Announcements
Zydus Lifesciences Reports Strong Q3 Financial Growth
12M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >